Kezar Life Sciences Inc

General ticker "KZR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $507.7M

Kezar Life Sciences Inc follows the US Stock Market performance with the rate: 12.6%.

Estimated limits based on current volatility of 2.6%: low 6.27$, high 6.60$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [4.46$, 13.47$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.96$, 10.79$]

Financial Metrics affecting the KZR estimates:

  • Negative: Non-GAAP EPS, $ of -13.20 <= 0.10
  • Negative: Operating profit margin, % of -93.76 <= 1.03
  • Negative: Operating cash flow per share per price, % of -11.66 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term KZR quotes

Long-term KZR plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $7.00MM
Operating Expenses $54.66MM $71.16MM $112.24MM
Operating Income $-54.66MM $-71.16MM $-105.24MM
Non-Operating Income $0.03MM $2.92MM $3.37MM
Interest Expense $0.16MM $1.19MM $1.55MM
R&D Expense $38.94MM $51.01MM $85.70MM
Income(Loss) $-54.63MM $-68.24MM $-101.87MM
Profit(Loss) $-54.63MM $-68.24MM $-101.87MM
Stockholders Equity $196.88MM $269.87MM $187.57MM
Inventory $2.50MM $0.00MM $0.00MM
Assets $217.93MM $299.57MM $221.24MM
Operating Cash Flow $-42.44MM $-58.85MM $-81.64MM
Capital expenditure $0.32MM $1.58MM $1.81MM
Investing Cash Flow $-28.44MM $-91.39MM $76.05MM
Financing Cash Flow $112.58MM $127.86MM $0.64MM
Earnings Per Share* $-1.01 $-0.97 $-1.40

* EPS are Split Adjusted, recent splits may be reflected with a delay.